BACKGROUND: Peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta) is a recently identified homologue of the tissue specific coactivator PGC-1alpha, a coactivator of transcription factors such as the peroxisome proliferators activated receptors and nuclear respiratory factors. PGC-1alpha is involved in adipogenesis, mitochondrial biogenesis, fatty acid beta oxidation, and hepatic gluconeogenesis. METHODS: We studied variation in the coding region of human PPARGC1B in Danish whites and related these variations to the prevalence of obesity and type 2 diabetes in population based samples. RESULTS: Twenty nucleotide variants were identified. In a study of 525 glucose tolerant subjects, the Ala203Pro and Val279Ile variants were in almost complete linkage disequilibrium (R2 = 0.958). In a case-control study of obesity involving a total of 7790 subjects, the 203Pro allele was significantly less frequent among obese participants (p = 0.004; minor allele frequencies: normal weight subjects 8.1% (95% confidence interval: 7.5 to 8.8), overweight subjects 7.6% (7.0 to 8.3), obese subjects 6.5% (5.6 to 7.3)). In a case-control study involving 1433 patients with type 2 diabetes and 4935 glucose tolerant control subjects, none of the examined variants were associated with type 2 diabetes. CONCLUSIONS: Variation of PGC-1beta may contribute to the pathogenesis of obesity, with a widespread Ala203 allele being a risk factor for the development of this common disorder.
BACKGROUND:Peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta) is a recently identified homologue of the tissue specific coactivator PGC-1alpha, a coactivator of transcription factors such as the peroxisome proliferators activated receptors and nuclear respiratory factors. PGC-1alpha is involved in adipogenesis, mitochondrial biogenesis, fatty acid beta oxidation, and hepatic gluconeogenesis. METHODS: We studied variation in the coding region of humanPPARGC1B in Danish whites and related these variations to the prevalence of obesity and type 2 diabetes in population based samples. RESULTS: Twenty nucleotide variants were identified. In a study of 525 glucose tolerant subjects, the Ala203Pro and Val279Ile variants were in almost complete linkage disequilibrium (R2 = 0.958). In a case-control study of obesity involving a total of 7790 subjects, the 203Pro allele was significantly less frequent among obeseparticipants (p = 0.004; minor allele frequencies: normal weight subjects 8.1% (95% confidence interval: 7.5 to 8.8), overweight subjects 7.6% (7.0 to 8.3), obese subjects 6.5% (5.6 to 7.3)). In a case-control study involving 1433 patients with type 2 diabetes and 4935 glucose tolerant control subjects, none of the examined variants were associated with type 2 diabetes. CONCLUSIONS: Variation of PGC-1beta may contribute to the pathogenesis of obesity, with a widespread Ala203 allele being a risk factor for the development of this common disorder.
Authors: L F Michael; Z Wu; R B Cheatham; P Puigserver; G Adelmant; J J Lehman; D P Kelly; B M Spiegelman Journal: Proc Natl Acad Sci U S A Date: 2001-03-13 Impact factor: 11.205
Authors: J C Yoon; P Puigserver; G Chen; J Donovan; Z Wu; J Rhee; G Adelmant; J Stafford; C R Kahn; D K Granner; C B Newgard; B M Spiegelman Journal: Nature Date: 2001-09-13 Impact factor: 49.962
Authors: S Wiltshire; A T Hattersley; G A Hitman; M Walker; J C Levy; M Sampson; S O'Rahilly; T M Frayling; J I Bell; G M Lathrop; A Bennett; R Dhillon; C Fletcher; C J Groves; E Jones; P Prestwich; N Simecek; P V Rao; M Wishart; G F Bottazzo; R Foxon; S Howell; D Smedley; L R Cardon; S Menzel; M I McCarthy Journal: Am J Hum Genet Date: 2001-08-01 Impact factor: 11.025
Authors: N Vionnet; El H Hani; S Dupont; S Gallina; S Francke; S Dotte; F De Matos; E Durand; F Leprêtre; C Lecoeur; P Gallina; L Zekiri; C Dina; P Froguel Journal: Am J Hum Genet Date: 2000-11-06 Impact factor: 11.025
Authors: Z Wu; P Puigserver; U Andersson; C Zhang; G Adelmant; V Mootha; A Troy; S Cinti; B Lowell; R C Scarpulla; B M Spiegelman Journal: Cell Date: 1999-07-09 Impact factor: 41.582
Authors: K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205
Authors: C Ling; L Wegner; G Andersen; P Almgren; T Hansen; O Pedersen; L Groop; A Vaag; P Poulsen Journal: Diabetologia Date: 2007-06-20 Impact factor: 10.122
Authors: Hannes Oberkofler; Michael Hafner; Thomas Felder; Franz Krempler; Wolfgang Patsch Journal: J Mol Med (Berl) Date: 2008-12-11 Impact factor: 4.599
Authors: Mete Civelek; Raffi Hagopian; Calvin Pan; Nam Che; Wen-pin Yang; Paul S Kayne; Niyas K Saleem; Henna Cederberg; Johanna Kuusisto; Peter S Gargalovic; Todd G Kirchgessner; Markku Laakso; Aldons J Lusis Journal: Hum Mol Genet Date: 2013-04-04 Impact factor: 6.150
Authors: Ingrid Dahlman; Andrea Dicker; Hong Jiao; Juha Kere; Lennart Blomqvist; Vanessa van Harmelen; Johan Hoffstedt; Knut Borch-Johnsen; Torben Jorgensen; Torben Hansen; Oluf Pedersen; Markku Laakso; Peter Arner Journal: Am J Hum Genet Date: 2007-05-02 Impact factor: 11.025